866-997-4948(US-Canada Toll Free)

Global Human Vaccines Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 99 Pages

This report studies the global market size of Human Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Vaccines in these regions.
This research report categorizes the global Human Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Human Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Human Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of Human Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Human Vaccines include
AstraZeneca
Bavarian Nordic
Bharat Biotech
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Mymetics
Novartis AG
Pfizer, Inc.
Sanofi
Shenzhen Kangtai Biological Products Co., Ltd.
Takeda Pharmaceutical Company Limited.

Market Size Split by Type
Pneumococcal
Influenza
Hepatitis
HPV
Meningococcal
Rotavirus
Measles
Typhoid
Combination
Market Size Split by Application
Pediatrics
Adolescents
Adults
Geriatrics

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Human Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Human Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Human Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Human Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Human Vaccines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Vaccines Market Size Growth Rate by Type
1.4.2 Pneumococcal
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 HPV
1.4.6 Meningococcal
1.4.7 Rotavirus
1.4.8 Measles
1.4.9 Typhoid
1.4.10 Combination
1.5 Market by Application
1.5.1 Global Human Vaccines Market Size Growth Rate by Application
1.5.2 Pediatrics
1.5.3 Adolescents
1.5.4 Adults
1.5.5 Geriatrics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Human Vaccines Market Size
2.1.1 Global Human Vaccines Revenue 2016-2025
2.1.2 Global Human Vaccines Sales 2016-2025
2.2 Human Vaccines Growth Rate by Regions
2.2.1 Global Human Vaccines Sales by Regions
2.2.2 Global Human Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Human Vaccines Sales by Manufacturers
3.1.1 Human Vaccines Sales by Manufacturers
3.1.2 Human Vaccines Sales Market Share by Manufacturers
3.1.3 Global Human Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Human Vaccines Revenue by Manufacturers
3.2.1 Human Vaccines Revenue by Manufacturers (2016-2018)
3.2.2 Human Vaccines Revenue Share by Manufacturers (2016-2018)
3.3 Human Vaccines Price by Manufacturers
3.4 Human Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Human Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Vaccines Product Category
3.4.3 Date of International Manufacturers Enter into Human Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Human Vaccines Sales by Type
4.2 Global Human Vaccines Revenue by Type
4.3 Human Vaccines Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Human Vaccines Breakdown Data by Application

6 North America
6.1 North America Human Vaccines by Countries
6.1.1 North America Human Vaccines Sales by Countries
6.1.2 North America Human Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Vaccines by Type
6.3 North America Human Vaccines by Application
6.4 North America Human Vaccines by Company

7 Europe
7.1 Europe Human Vaccines by Countries
7.1.1 Europe Human Vaccines Sales by Countries
7.1.2 Europe Human Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Vaccines by Type
7.3 Europe Human Vaccines by Application
7.4 Europe Human Vaccines by Company

8 Asia Pacific
8.1 Asia Pacific Human Vaccines by Countries
8.1.1 Asia Pacific Human Vaccines Sales by Countries
8.1.2 Asia Pacific Human Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Human Vaccines by Type
8.3 Asia Pacific Human Vaccines by Application
8.4 Asia Pacific Human Vaccines by Company

9 Central & South America
9.1 Central & South America Human Vaccines by Countries
9.1.1 Central & South America Human Vaccines Sales by Countries
9.1.2 Central & South America Human Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Human Vaccines by Type
9.3 Central & South America Human Vaccines by Application
9.4 Central & South America Human Vaccines by Company

10 Middle East and Africa
10.1 Middle East and Africa Human Vaccines by Countries
10.1.1 Middle East and Africa Human Vaccines Sales by Countries
10.1.2 Middle East and Africa Human Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Vaccines by Type
10.3 Middle East and Africa Human Vaccines by Application
10.4 Middle East and Africa Human Vaccines by Company

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Human Vaccines
11.1.4 Human Vaccines Product Description
11.1.5 Recent Development
11.2 Bavarian Nordic
11.2.1 Bavarian Nordic Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Human Vaccines
11.2.4 Human Vaccines Product Description
11.2.5 Recent Development
11.3 Bharat Biotech
11.3.1 Bharat Biotech Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Human Vaccines
11.3.4 Human Vaccines Product Description
11.3.5 Recent Development
11.4 CSL Limited
11.4.1 CSL Limited Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Human Vaccines
11.4.4 Human Vaccines Product Description
11.4.5 Recent Development
11.5 Emergent BioSolutions, Inc.
11.5.1 Emergent BioSolutions, Inc. Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Human Vaccines
11.5.4 Human Vaccines Product Description
11.5.5 Recent Development
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Human Vaccines
11.6.4 Human Vaccines Product Description
11.6.5 Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Human Vaccines
11.7.4 Human Vaccines Product Description
11.7.5 Recent Development
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Human Vaccines
11.8.4 Human Vaccines Product Description
11.8.5 Recent Development
11.9 Mymetics
11.9.1 Mymetics Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Human Vaccines
11.9.4 Human Vaccines Product Description
11.9.5 Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Human Vaccines
11.10.4 Human Vaccines Product Description
11.10.5 Recent Development
11.11 Pfizer, Inc.
11.12 Sanofi
11.13 Shenzhen Kangtai Biological Products Co., Ltd.
11.14 Takeda Pharmaceutical Company Limited.

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Human Vaccines Raw Material
13.1.2 Human Vaccines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Human Vaccines
Figure Global Human Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Human Vaccines Production Market Share by Types (Product Category) in 2017
Figure Pneumococcal Product Picture
Table Major Manufacturers of Pneumococcal
Figure Influenza Product Picture
Table Major Manufacturers of Influenza
Figure Hepatitis Product Picture
Table Major Manufacturers of Hepatitis
Figure HPV Product Picture
Table Major Manufacturers of HPV
Figure Meningococcal Product Picture
Table Major Manufacturers of Meningococcal
Figure Rotavirus Product Picture
Table Major Manufacturers of Rotavirus
Figure Measles Product Picture
Table Major Manufacturers of Measles
Figure Typhoid Product Picture
Table Major Manufacturers of Typhoid
Figure Combination Product Picture
Table Major Manufacturers of Combination
Table Global Human Vaccines Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Pediatrics
Figure Adolescents
Figure Adults
Figure Geriatrics
Figure Human Vaccines Report Years Considered
Figure Global Human Vaccines Market Size 2016-2025 (Million US$)
Figure Global Human Vaccines Sales 2016-2025 (K Units)
Table Global Human Vaccines Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Human Vaccines Sales by Regions 2016-2025 (K Units)
Table Global Human Vaccines Sales Market Share by Regions 2016-2025
Figure Global Human Vaccines Sales Market Share by Regions 2016-2025
Figure 2017 Global Human Vaccines Sales Market Share by Regions
Table Global Human Vaccines Revenue by Regions 2016-2025 (Million US$)
Table Global Human Vaccines Revenue Market Share by Regions 2016-2025
Figure Global Human Vaccines Revenue Market Share by Regions 2016-2025
Figure 2017 Global Human Vaccines Revenue Market Share by Regions
Table Global Human Vaccines Sales by Manufacturers (2016-2018) (K Units)
Table Global Human Vaccines Sales Share by Manufacturers (2016-2018)
Figure Global Human Vaccines Sales Share by Manufacturers in 2017
Table Human Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
Table Human Vaccines Revenue Share by Manufacturers (2016-2018)
Figure Human Vaccines Value Share by Manufacturers in 2017
Table Global Human Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Human Vaccines Price (2016-2018) (USD/Unit)
Table Human Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Human Vaccines Product Category
Table Date of International Manufacturers Enter into Human Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Human Vaccines Sales by Type (2016-2025) (K Units)
Table Global Human Vaccines Sales Share by Type (2016-2025)
Figure Global Human Vaccines Sales Market Share by Type (2016-2025)
Figure Global Human Vaccines Sales Market Share by Type in 2017
Table Global Human Vaccines Revenue by Type (2016-2025) (Million US$)
Table Global Human Vaccines Revenue Share by Type (2016-2025)
Figure Global Human Vaccines Revenue Market Share by Type (2016-2025)
Figure Global Human Vaccines Revenue Market Share by Type in 2017
Table Human Vaccines Price by Type 2013-2018 (USD/Unit)
Table Global Human Vaccines Sales by Application (2016-2025) (K Units)
Table Global Human Vaccines Sales Share by Application (2016-2025)
Figure Global Sales Human Vaccines Market Share by Application (2016-2025)
Figure Global Sales Human Vaccines Market Share by Application (2016-2025)
Figure North America Human Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure North America Human Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table North America Human Vaccines Sales by Countries (2016-2025) (K Units)
Table North America Human Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 North America Human Vaccines Sales Market Share by Countries
Table North America Human Vaccines Revenue by Countries (2016-2025) (Million US$)
Table North America Human Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Human Vaccines Revenue Market Share by Countries
Figure United States Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure United States Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Canada Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table North America Human Vaccines Sales by Type (2016-2025) (K Units)
Table North America Human Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 North America Human Vaccines Market Share by Type
Table North America Human Vaccines Sales by Application (2016-2025) (K Units)
Table North America Human Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 North America Human Vaccines Market Share by Application
Table North America Human Vaccines Sales by Company (2016-2018) (K Units)
Table North America Human Vaccines Sales Market Share by Company (2016-2018)
Figure North America Human Vaccines Sales Market Share by Company in 2017
Figure Europe Human Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Europe Human Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Human Vaccines Sales by Countries (2016-2025) (K Units)
Table Europe Human Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Human Vaccines Sales Market Share by Countries
Table Europe Human Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Europe Human Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Human Vaccines Revenue Market Share by Countries
Figure Germany Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Germany Human Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure France Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure France Human Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure UK Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure UK Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Italy Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Russia Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Human Vaccines Sales by Type (2016-2025) (K Units)
Table Europe Human Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Europe Human Vaccines Market Share by Type
Table Europe Human Vaccines Sales by Application (2016-2025) (K Units)
Table Europe Human Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Europe Human Vaccines Market Share by Application
Table Europe Human Vaccines Sales by Company (2016-2018) (K Units)
Table Europe Human Vaccines Sales Market Share by Company (2016-2018)
Figure Europe Human Vaccines Sales Market Share by Company in 2017
Figure Asia Pacific Human Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Human Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Human Vaccines Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Human Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Human Vaccines Sales Market Share by Countries
Table Asia Pacific Human Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Human Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Human Vaccines Revenue Market Share by Countries
Figure China Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure China Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Japan Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Korea Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure India Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure India Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Australia Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Human Vaccines Sales by Type (2016-2025) (K Units)
Table Asia Pacific Human Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Human Vaccines Market Share by Type
Table Asia Pacific Human Vaccines Sales by Application (2016-2025) (K Units)
Table Asia Pacific Human Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Human Vaccines Market Share by Application
Table Asia Pacific Human Vaccines Sales by Company (2016-2018) (K Units)
Table Asia Pacific Human Vaccines Sales Market Share by Company (2016-2018)
Figure Asia Pacific Human Vaccines Sales Market Share by Company in 2017
Figure Central & South America Human Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Human Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Human Vaccines Sales by Countries (2016-2025) (K Units)
Table Central & South America Human Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Human Vaccines Sales Market Share by Countries
Table Central & South America Human Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Human Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Human Vaccines Revenue Market Share by Countries
Figure Brazil Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Human Vaccines Sales by Type (2016-2025) (K Units)
Table Central & South America Human Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Human Vaccines Market Share by Type
Table Central & South America Human Vaccines Sales by Application (2016-2025) (K Units)
Table Central & South America Human Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Human Vaccines Market Share by Application
Table Central & South America Human Vaccines Sales by Company (2016-2018) (K Units)
Table Central & South America Human Vaccines Sales Market Share by Company (2016-2018)
Figure Central & South America Human Vaccines Sales Market Share by Company in 2017
Figure Middle East and Africa Human Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Human Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Human Vaccines Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Human Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Human Vaccines Sales Market Share by Countries
Table Middle East and Africa Human Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Human Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Human Vaccines Revenue Market Share by Countries
Figure GCC Countries Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Human Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Human Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Human Vaccines Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Human Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Human Vaccines Market Share by Type
Table Middle East and Africa Human Vaccines Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Human Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Human Vaccines Market Share by Application
Table Middle East and Africa Human Vaccines Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Human Vaccines Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Human Vaccines Sales Market Share by Company in 2017
Table AstraZeneca Company Details
Table AstraZeneca Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Bavarian Nordic Company Details
Table Bavarian Nordic Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bavarian Nordic Recent Development
Table Bharat Biotech Company Details
Table Bharat Biotech Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bharat Biotech Recent Development
Table CSL Limited Company Details
Table CSL Limited Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table CSL Limited Recent Development
Table Emergent BioSolutions, Inc. Company Details
Table Emergent BioSolutions, Inc. Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Emergent BioSolutions, Inc. Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline plc Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck & Co., Inc. Recent Development
Table Mymetics Company Details
Table Mymetics Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mymetics Recent Development
Table Novartis AG Company Details
Table Novartis AG Human Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis AG Recent Development
Table Pfizer, Inc. Company Details
Table Sanofi Company Details
Table Shenzhen Kangtai Biological Products Co., Ltd. Company Details
Table Takeda Pharmaceutical Company Limited. Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Human Vaccines Value Chain
Table Typical Suppliers of Key Human Vaccines Raw Material
Table Human Vaccines Customers List
Table Human Vaccines Sales Channels
Table Human Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *